We recently published a list of Top 10 Insider Purchases Last Month. In this article, we are going to take a look at where ...

We recently published a list of 10 Stocks With At Least $10 Million In Insider Spending Recently. In this article, we are ...

The newly listed clinical-stage biotechnology company, Metsera Inc. rose 15.01% on Monday as the broader markets declined.

We recently published a list of 10 Stocks With At Least $20 Million In Insider Spending Recently. In this article, we are ...

Metsera , Inc. (NASDAQ:MTSR), a pharmaceutical company with a market capitalization of $2.68 billion, has disclosed the approval of 2024 annual cash bonuses for its named executive officers ...

Metsera’s (NASDAQ:MTSR – Get Free Report) quiet period is set to expire on Wednesday, March 12th. Metsera had issued 15,277,778 shares in its initial public offering on January 31st. The total size of ...

Metsera , Inc. (NASDAQ:MTSR), a pharmaceutical company with a market capitalization of $2.68 billion, has disclosed the approval of 2024 annual cash bonuses for its named executive officers, following ...

Guggenheim has initiated coverage of Metsera (NASDAQ:MTSR) with a buy rating, citing the company's obesity drug candidates. The bank highlighted Metsera's (NASDAQ:MTSR) long-acting GLP-1RA asset ...

Metsera (NASDAQ:MTSR) was able to complete its initial public offering [IPO] back on February 3rd of 2025. Before taking expenses into account, it was able to generate net proceeds of about $316.2 ...